|
$2,000.00
By: GlobalData, Published: Sep-2010
GlobalData, the industry analysis specialist, has released its new report, “Hepatitis B - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Hepatitis B therapeutics market. The report identifies the key trends shaping and driving the global Hepatitis B therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected .....
|
|
|
$3,500.00
By: GBI Research, Published: Sep-2010
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis", provides in-depth analysis of unmet needs, drivers and barriers that impact the global musculoskeletal disorders market. The report analyzes the markets for musculoskeletal disorders in the US, the top five countries in Europe (the UK, .....
|
|
|
$3,500.00
By: GBI Research, Published: Sep-2010
GBI Research’s pharmaceuticals report, “Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Vaccine Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics market. The report analyzes the markets for hepatitis therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain).....
|
|
|
$3,500.00
By: GBI Research, Published: Sep-2010
GBI Research's pharmaceutical report, “Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies' Adoption of New Sales Models and Technologies” provides key data, information and analysis of the major trends and practices adopted to improve the sales force effectiveness in the pharmaceutical industry. The report provides a comprehensive insight of the various strategies adopted by pharmaceutical companies t.....
|
|
|
$3,500.00
By: GBI Research, Published: Sep-2010
GBI Research's pharmaceutical and healthcare report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biolog.....
|
|
|
$2,000.00
By: GlobalData, Published: Aug-2010
GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Pipeline Assessemnt and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report identifies the key trends shaping and driving the global type 2 diabetes therapeutics market. The report also provides insights into the competitive landscape and the emerging playe.....
|
|
|
$3,500.00
By: GBI Research, Published: Aug-2010
GBI Research’s Therapeutic Analysis report, “Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global urological disorders market. This pharmaceutical and healthcare report analyzes the markets for urological disorders in the US, the top five countries in.....
|
|
|
$3,500.00
By: GBI Research, Published: Aug-2010
GBI Research’s report, “Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global women’s health market. The report analyzes the markets for women’s health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, pric.....
|
|
|
$3,500.00
By: GBI Research, Published: Aug-2010
GBI Research’s report, “Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors will Dominate the Market”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global men’s health market. The report analyzes the markets for men’s health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and.....
|
|
|
$3,500.00
By: GBI Research, Published: Aug-2010
GBI Research's report, “Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge” provides key data, information and analysis of the major trends and issues affecting the global contract sales organizations. The report provides a comprehensive insight into the difference between pharma sales and contract sales models. It also provides an insight int.....
|
|
|
$3,500.00
By: GBI Research, Published: Aug-2010
GBI Research's pharmaceutical research, “Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma" provides insights on segments where epigenetic therapies may prove to be useful. The report also details the market potential for the epigenetic therapies. Furthermore, it provides insights into the epigenetic therapeutics R&D pipeline. The report also co.....
|
|
|
$7,695.00
By: Cutting Edge Information, Published: Aug-2010
Once primarily viewed as sales support, Medical Science Liaisons (MSLs) now sit at the center of multiple activities. Organizations leverage MSLs’ unique combination of scientific expertise and relationship-building acumen to build thought leader connections and to shape clinical and commercial strategy. These responsibilities have amplified the professional and educational experience required of MSLs, and superlative MSL management now requires .....
|
|
|
$1,500.00
By: GlobalData, Published: Aug-2010
"GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceu.....
|
|
|
$1,215.00
By: Espicom, Published: Aug-2010
"While Biomarker research is still in its infancy, great strides have been made in the discovery and utilisation of biomarkers in the development of targeted cancer therapeutics and companion diagnostics. Furthermore, there are still significant opportunities in other disease areas to improve productivity by identifying the most suitable developmental candidates earlier during the R&D process.Stakeholder engagement is critical-All stakeholders ha.....
|
|
|
$1,000.00
By: GlobalData, Published: Aug-2010
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharma.....
|
|
|
$800.00
By: Koncept Analytics, Published: Aug-2010
The global radiation therapy market has witnessed a double digit growth rate during the last few years. The industry growth was driven by technological advancements which have made radiation therapy more effective, precise and above all commercially viable. Higher cancer incidence and favorable reimbursement policy in the developed countries like U.S., U.K. further helped the industry in achieving double digit growth rate.
The U.S. is the.....
|
|
|
$2,000.00
By: GlobalData, Published: Jul-2010
GlobalData, the industry analysis specialist, has released a new report, “Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global allergic rhinitis market. The report identifies the key trends shaping and driving the global allergic rhinitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to .....
|
|
|
$3,400.00
By: TriMark Publications, LLC, Published: Jul-2010
This TriMark Publications report describes latest developments in the point of care diagnostic testing (POCT) market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections--both in the U.S. and worldwide--including.....
|
|
|
$4,000.00
By: Jain PharmaBiotech, Published: Jul-2010
The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of molecular diagnostics play an important role, par.....
|
|
|
$4,500.00
By: Jain PharmaBiotech, Published: Jul-2010
Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of vectors and various techniques are being used to modify the function of genes in vivo without gene transfer. If one adds to this the cell therapy particularly with use of genetically modified cel.....
|
|
|
$4,500.00
By: Jain PharmaBiotech, Published: Jul-2010
Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare. The report starts with an introduction to various techniques and materials t.....
|
|
|
$4,500.00
By: Jain PharmaBiotech, Published: Jul-2010
This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since th.....
|
|
|
$5,000.00
By: Jain PharmaBiotech, Published: Jul-2010
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.
Stem cells are discussed in detail in one chapter. Some light is thrown on the curr.....
|
|
|
$5,000.00
By: Jain PharmaBiotech, Published: Jul-2010
This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, biochips, nanotechnology and proteomic techn.....
|
|
|
$7,695.00
By: Cutting Edge Information, Published: Jul-2010
Once primarily viewed as sales support, Medical Science Liaisons (MSLs) now sit at the center of multiple activities. Organizations leverage MSLs’ unique combination of scientific expertise and relationship-building acumen to build thought leader connections and to shape clinical and commercial strategy. These responsibilities have amplified the professional and educational experience required of MSLs, and superlative MSL management now requires .....
|
|